speb/financial-data huggingface dataset:
Financial ratios for CR — annual report dated 2024-12-31
Total revenue: 2131200000
Gross profit: 867800000
Operating income: 355800000
Net income: 294700000
Capital expenditures: 36600000
Operating cash flow: 257800000
Depreciation & amortization: 51000000
Net tangible assets: 817200000
Owner earnings: 309100000
Return on net tangible assets (%): 37.824278022515905
Capex to operating income (%): 10.286677908937605
Buffett classification: The Great
Stock price: 150.56
P/E ratio: 29.501834014794706
Shares outstanding: 57745686
Book value: 1641000000
P/B ratio: 5.298105109177331
Market cap (USD): 8694190484.16
Debt to equity: 0.19457647775746495
Current ratio: 2.5822598454177403
Quick ratio: 1.8822230401177769
Effective tax rate (%): 20.768094534711963
Interest coverage ratio: 13.080882352941176
COGS to revenue (%): 59.28115615615616
SG&A to revenue (%): 24.024024024024023
Free cash flow (dilution-adjusted): 195600000
Buyback yield (%): 0
Retained earnings: 1217800000
Inventory turnover: 3.32124079915878
Receivables turnover: 6.284871719256857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.954967834167263
FCF margin (%): 9.177927927927929
Revenue growth (%): 14.451425809569841
Rule of 40 score: 23.62935373749777
Financial ratios for CR — quarterly report dated 2025-03-31
Total revenue: 557600000
Gross profit: 237600000
Operating income: 101100000
Net income: 107100000
Capital expenditures: 14200000
Operating cash flow: -46200000
Depreciation & amortization: 12500000
Net tangible assets: 930200000
Owner earnings: 105400000
Return on net tangible assets (%): 11.330896581380347
Capex to operating income (%): 14.045499505440159
Buffett classification: The Great
Stock price: 152.2
P/E ratio: 20.515624204481792
Shares outstanding: 57745686
Book value: 1759200000
P/B ratio: 4.995960328103683
Market cap (USD): 8788893409.199999
Debt to equity: 0.14773760800363803
Current ratio: 2.0826383623957545
Quick ratio: 1.488855193328279
Effective tax rate (%): 20.748987854251013
Interest coverage ratio: 22.466666666666665
COGS to revenue (%): 57.388809182209464
SG&A to revenue (%): 24.479913916786227
Free cash flow (dilution-adjusted): -69700000
Buyback yield (%): 0
Retained earnings: 1311700000
Inventory turnover: 0.8171603677221655
Receivables turnover: 1.4505723204994798
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.151329868541731
FCF margin (%): -12.5
Rule of 40 score: -12.5
Financial ratios for CR — quarterly report dated 2025-06-30
Total revenue: 577200000
Gross profit: 242300000
Operating income: 102900000
Net income: 86400000
Capital expenditures: 16100000
Operating cash flow: 105000000
Depreciation & amortization: 13100000
Net tangible assets: 1045300000
Owner earnings: 83400000
Return on net tangible assets (%): 7.978570745240601
Capex to operating income (%): 15.646258503401361
Buffett classification: The Great
Stock price: 188.92
P/E ratio: 56.37888888434109
Shares outstanding: 57745686
Book value: 1888600000
P/B ratio: 5.776403155310812
Market cap (USD): 10909314999.119999
Debt to equity: 0.03192841258074764
Current ratio: 2.92737955346651
Quick ratio: 1.98213866039953
Effective tax rate (%): 23.23135755258126
Interest coverage ratio: 23.930232558139537
COGS to revenue (%): 58.02148302148302
SG&A to revenue (%): 24.151074151074152
Free cash flow (dilution-adjusted): 78300000
Buyback yield (%): 0
Retained earnings: 1384900000
Inventory turnover: 0.8326703132769766
Receivables turnover: 1.5043002345582486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.920855052364784
FCF margin (%): 13.565488565488565
Revenue growth (%): 3.5150645624103296
Rule of 40 score: 17.080553127898895
Financial ratios for CR — quarterly report dated 2025-09-30
Total revenue: 589200000
Gross profit: 251300000
Operating income: 118400000
Net income: 91400000
Capital expenditures: 13400000
Operating cash flow: 130200000
Depreciation & amortization: 12200000
Net tangible assets: 1129400000
Owner earnings: 90200000
Return on net tangible assets (%): 7.986541526474234
Capex to operating income (%): 11.317567567567567
Buffett classification: The Great
Stock price: 183.42
P/E ratio: 37.17695235563355
Shares outstanding: 57745686
Book value: 1968500000
P/B ratio: 5.380601334071628
Market cap (USD): 10591713726.119999
Debt to equity: 0.006858013716027432
Current ratio: 3.2660714285714287
Quick ratio: 2.259183673469388
Effective tax rate (%): 24.086378737541526
Interest coverage ratio: 118.4
COGS to revenue (%): 57.3489477257298
SG&A to revenue (%): 22.55600814663951
Free cash flow (dilution-adjusted): 111300000
Buyback yield (%): 0
Retained earnings: 1463000000
Inventory turnover: 0.8560932353686344
Receivables turnover: 1.5189481825212683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.489105238757533
FCF margin (%): 18.89002036659878
Revenue growth (%): 2.079002079002079
Rule of 40 score: 20.96902244560086
Financial ratios for CR — annual report dated 2025-12-31
Total revenue: 2305000000
Gross profit: 972800000
Operating income: 424200000
Net income: 366600000
Capital expenditures: 53500000
Operating cash flow: 394800000
Depreciation & amortization: 50200000
Net tangible assets: 1227700000
Owner earnings: 363300000
Return on net tangible assets (%): 29.591919850126253
Capex to operating income (%): 12.611975483262611
Buffett classification: The Great
Stock price: 183.94
P/E ratio: 28.973653799345335
Shares outstanding: 57745686
Book value: 2063400000
P/B ratio: 5.147689000116312
Market cap (USD): 10621741482.84
Debt to equity: 0.5894155277697005
Current ratio: 5.527515047291487
Quick ratio: 4.718185726569217
Effective tax rate (%): 23.35951940850277
Interest coverage ratio: 37.53982300884956
COGS to revenue (%): 57.79609544468547
SG&A to revenue (%): 23.800433839479393
Free cash flow (dilution-adjusted): 314100000
Buyback yield (%): 0
Retained earnings: 1531500000
Inventory turnover: 3.5383798140770253
Receivables turnover: 6.425982715361026
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.519922082521692
FCF margin (%): 13.626898047722344
Revenue growth (%): 8.15503003003003
Rule of 40 score: 21.781928077752376
Financial ratios for CR — quarterly report dated 2025-12-31
Total revenue: 581000000
Gross profit: 241600000
Operating income: 101800000
Net income: 81700000
Capital expenditures: 9800000
Operating cash flow: 205800000
Depreciation & amortization: 12400000
Net tangible assets: 1227700000
Owner earnings: 84300000
Return on net tangible assets (%): 6.866498330210964
Capex to operating income (%): 9.62671905697446
Buffett classification: The Great
Stock price: 183.94
P/E ratio: 28.973653799345335
Shares outstanding: 57745686
Book value: 2063400000
P/B ratio: 5.147689000116312
Market cap (USD): 10621741482.84
Debt to equity: 0.5894155277697005
Current ratio: 5.527515047291487
Quick ratio: 4.718185726569217
Effective tax rate (%): 25.045871559633028
Interest coverage ratio: 67.86666666666666
COGS to revenue (%): 58.41652323580034
SG&A to revenue (%): 24.061962134251292
Free cash flow (dilution-adjusted): 194200000
Buyback yield (%): 0
Retained earnings: 1531500000
Inventory turnover: 0.901460823373174
Receivables turnover: 1.619737942570393
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.004545186234579
FCF margin (%): 33.425129087779695
Revenue growth (%): -1.3917175831636117
Rule of 40 score: 32.03341150461608
Financial ratios for CRI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 83.75
Shares outstanding: 36850117
Market cap (USD): 3086197298.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRI — annual report dated 2022-12-31
Total revenue: 3212733000
Gross profit: 1472358000
Operating income: 388171000
Net income: 250038000
Capital expenditures: 40364000
Operating cash flow: 88361000
Depreciation & amortization: 65276000
Net tangible assets: 258119000
Owner earnings: 274950000
Return on net tangible assets (%): 106.52063583076024
Capex to operating income (%): 10.398509935054397
Buffett classification: The Great
Stock price: 64.11
P/E ratio: 9.448407845487486
Shares outstanding: 36850117
Book value: 796409000
P/B ratio: 2.966391641568591
Market cap (USD): 2362461000.87
Debt to equity: 1.4826515019292852
Current ratio: 2.2473244112381345
Quick ratio: 0.8396783054699035
Effective tax rate (%): 21.05791574055365
Interest coverage ratio: 9.073443818517566
COGS to revenue (%): 54.171168285693206
SG&A to revenue (%): 34.55024118095093
Free cash flow (dilution-adjusted): 26118000
Buyback yield (%): 12.684526851010222
Retained earnings: 830370000
Inventory turnover: 2.3374135242615566
Receivables turnover: 16.177962303675468
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.314941756342744
FCF margin (%): 0.8129527103559494
Rule of 40 score: 0.8129527103559494
Financial ratios for CRI — annual report dated 2023-12-31
Total revenue: 2945594000
Gross profit: 1395935000
Operating income: 323405000
Net income: 232500000
Capital expenditures: 59860000
Operating cash flow: 529132000
Depreciation & amortization: 64139000
Net tangible assets: 309289000
Owner earnings: 236779000
Return on net tangible assets (%): 76.55590725826006
Capex to operating income (%): 18.50929948516566
Buffett classification: The Great
Stock price: 67.24
P/E ratio: 10.657212331526882
Shares outstanding: 36850117
Book value: 845250000
P/B ratio: 2.9314426111564624
Market cap (USD): 2477801867.08
Debt to equity: 1.2795421472937
Current ratio: 2.15144511606644
Quick ratio: 1.1020900164497462
Effective tax rate (%): 23.0748870110706
Interest coverage ratio: 9.519471344891532
COGS to revenue (%): 52.60938880239435
SG&A to revenue (%): 37.13817993925843
Free cash flow (dilution-adjusted): 449809000
Buyback yield (%): 4.0372073864762426
Retained earnings: 868799000
Inventory turnover: 2.885099371654643
Receivables turnover: 16.02835003863441
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.324485161652518
FCF margin (%): 15.270570214360838
Revenue growth (%): -8.315007814219232
Rule of 40 score: 6.955562400141606
Financial ratios for CRI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 60.34
Shares outstanding: 36850117
Market cap (USD): 2223536059.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRI — annual report dated 2024-12-31
Total revenue: 2844102000
Gross profit: 1365166000
Operating income: 284728000
Net income: 185509000
Capital expenditures: 56165000
Operating cash flow: 298787000
Depreciation & amortization: 57926000
Net tangible assets: 356136000
Owner earnings: 187270000
Return on net tangible assets (%): 52.58384437405935
Capex to operating income (%): 19.725843612149138
Buffett classification: The Great
Stock price: 51.08
P/E ratio: 10.14669895455207
Shares outstanding: 36850117
Book value: 854562000
P/B ratio: 2.202653495428067
Market cap (USD): 1882303976.36
Debt to equity: 1.3225418401473503
Current ratio: 2.2457469890883934
Quick ratio: 1.2584902990471998
Effective tax rate (%): 19.626617679553224
Interest coverage ratio: 9.087740576425904
COGS to revenue (%): 52.00010407502966
SG&A to revenue (%): 38.66559638156438
Free cash flow (dilution-adjusted): 224781000
Buyback yield (%): 2.684263574563934
Retained earnings: 894024000
Inventory turnover: 2.9441405285747275
Receivables turnover: 14.597565106706222
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.79605331875526
FCF margin (%): 7.90340852754226
Revenue growth (%): -3.4455529173402715
Rule of 40 score: 4.457855610201989
Financial ratios for CRI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.08
Shares outstanding: 36850117
Market cap (USD): 1882303976.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRI — quarterly report dated 2025-03-31
Total revenue: 629827000
Gross profit: 291090000
Operating income: 26102000
Net income: 15539000
Capital expenditures: 10346000
Operating cash flow: -48644000
Depreciation & amortization: 13254000
Net tangible assets: 348612000
Owner earnings: 18447000
Return on net tangible assets (%): 5.29155622870125
Capex to operating income (%): 39.63680943988967
Buffett classification: The Good
Stock price: 39.31
P/E ratio: 23.30552318794646
Shares outstanding: 36850117
Book value: 847245000
P/B ratio: 1.7097511336980449
Market cap (USD): 1448578099.27
Debt to equity: 1.3248965765510567
Current ratio: 2.562641384061405
Quick ratio: 1.4043938379756977
Effective tax rate (%): 27.214389432760317
Interest coverage ratio: 3.3382785522445326
COGS to revenue (%): 53.782546635822214
SG&A to revenue (%): 42.91972239996063
Free cash flow (dilution-adjusted): -68743000
Buyback yield (%): 0
Retained earnings: 880564000
Inventory turnover: 0.7144481190574618
Receivables turnover: 3.089310502126324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3577438003718163
FCF margin (%): -10.914584481135297
Rule of 40 score: -10.914584481135297
Financial ratios for CRI — quarterly report dated 2025-06-30
Total revenue: 585313000
Gross profit: 281760000
Operating income: 4044000
Net income: 446000
Capital expenditures: 16200000
Operating cash flow: 40306000
Depreciation & amortization: 13559000
Net tangible assets: 354255000
Owner earnings: -2195000
Return on net tangible assets (%): -0.619610167816968
Capex to operating income (%): 400.59347181008906
Buffett classification: The Gruesome
Stock price: 29.19
P/E ratio: 67.291518
Shares outstanding: 36850117
Book value: 853902000
P/B ratio: 1.259693636072992
Market cap (USD): 1075654915.23
Debt to equity: 1.3167049614592776
Current ratio: 2.2033191863351793
Quick ratio: 1.025635806426453
Effective tax rate (%): 73.81092190252495
Interest coverage ratio: 0.5147002672775869
COGS to revenue (%): 51.8616535084647
SG&A to revenue (%): 48.002521727691
Free cash flow (dilution-adjusted): 18918000
Buyback yield (%): 0
Retained earnings: 871894000
Inventory turnover: 0.49033395038396055
Receivables turnover: 4.170321762425901
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.20954659898719144
FCF margin (%): 3.232116833215733
Revenue growth (%): -7.067655086237967
Rule of 40 score: -3.8355382530222344
Financial ratios for CRI — quarterly report dated 2025-09-30
Total revenue: 757836000
Gross profit: 341628000
Operating income: 29093000
Net income: 11593000
Capital expenditures: 16116000
Operating cash flow: -127972000
Depreciation & amortization: 13765000
Net tangible assets: 366580000
Owner earnings: 9242000
Return on net tangible assets (%): 2.521141360685253
Capex to operating income (%): 55.39476850101399
Buffett classification: The Good
Stock price: 27.6
P/E ratio: 36.879513713829866
Shares outstanding: 36850117
Book value: 864642000
P/B ratio: 1.176282472052017
Market cap (USD): 1017063229.2
Debt to equity: 1.3629051098604972
Current ratio: 2.2599234587095616
Quick ratio: 0.9520460842352847
Effective tax rate (%): 21.84845624915734
Interest coverage ratio: 4.055904084762303
COGS to revenue (%): 54.92058967903346
SG&A to revenue (%): 41.95670303337398
Free cash flow (dilution-adjusted): -147814000
Buyback yield (%): 0
Retained earnings: 874355000
Inventory turnover: 0.6343193390525628
Receivables turnover: 3.1653391363186407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.478491413284926
FCF margin (%): -19.504747729060114
Revenue growth (%): 29.47534054428998
Rule of 40 score: 9.970592815229868
Financial ratios for CRI — annual report dated 2025-12-31
Total revenue: 2898426000
Gross profit: 1314636000
Operating income: 143933000
Net income: 91796000
Capital expenditures: 53704000
Operating cash flow: 122334000
Depreciation & amortization: 55263000
Net tangible assets: 427267000
Owner earnings: 93355000
Return on net tangible assets (%): 21.84933542726211
Capex to operating income (%): 37.311804798065765
Buffett classification: The Good
Stock price: 31.98
P/E ratio: 12.83788772560896
Shares outstanding: 36850117
Book value: 925048000
P/B ratio: 1.2739519913128832
Market cap (USD): 1178466741.66
Debt to equity: 1.3103341664432548
Current ratio: 2.5114239807745897
Quick ratio: 1.4350855835113647
Effective tax rate (%): 19.359769488904895
Interest coverage ratio: 4.205247319367751
COGS to revenue (%): 54.643106292863784
SG&A to revenue (%): 41.01553739857426
Free cash flow (dilution-adjusted): 48382000
Buyback yield (%): 0
Retained earnings: 929461000
Inventory turnover: 2.9080429801110492
Receivables turnover: 16.23167904304291
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.988826753251924
FCF margin (%): 1.669250827863123
Revenue growth (%): 1.9100580780858072
Rule of 40 score: 3.5793089059489303
Financial ratios for CRI — quarterly report dated 2025-12-31
Total revenue: 925451000
Gross profit: 400158000
Operating income: 84693000
Net income: 64218000
Capital expenditures: 11042000
Operating cash flow: 258644000
Depreciation & amortization: 14685000
Net tangible assets: 427267000
Owner earnings: 67861000
Return on net tangible assets (%): 15.882574596212674
Capex to operating income (%): 13.037677257860745
Buffett classification: The Great
Stock price: 31.98
P/E ratio: 12.83788772560896
Shares outstanding: 36850117
Book value: 925048000
P/B ratio: 1.2739519913128832
Market cap (USD): 1178466741.66
Debt to equity: 1.3103341664432548
Current ratio: 2.5114239807745897
Quick ratio: 1.4350855835113647
Effective tax rate (%): 15.444778006004109
Interest coverage ratio: 7.4435753207945154
COGS to revenue (%): 56.76075772785377
SG&A to revenue (%): 34.53008317025969
Free cash flow (dilution-adjusted): 246021000
Buyback yield (%): 0
Retained earnings: 929461000
Inventory turnover: 0.9645057874790681
Receivables turnover: 5.182683153567869
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.112362725804126
FCF margin (%): 26.58390341574
Revenue growth (%): 22.117582168173588
Rule of 40 score: 48.70148558391359
Financial ratios for CTAI.L — annual report dated 2021-09-30
Total revenue: 40824.32432432433
Gross profit: 21364.864864864867
Operating income: -1247590.5405405406
Net income: -1685064.8648648649
Capital expenditures: 0
Operating cash flow: -1342086.4864864864
Depreciation & amortization: 0
Net tangible assets: 500550
Owner earnings: -1685064.8648648649
Return on net tangible assets (%): -336.6426660403286
Buffett classification: The Gruesome
Stock price: 0.0005405405405405405
Shares outstanding: 1433860312
Book value: 516116.2162162162
P/B ratio: 1.5017153186742982
Market cap (USD): 775059.6281081081
Debt to equity: 0
Current ratio: 2.3628938198756635
Quick ratio: 2.3628938198756635
COGS to revenue (%): 47.666335650446875
SG&A to revenue (%): 3108.3316782522343
Free cash flow (dilution-adjusted): -1342086.4864864864
Buyback yield (%): 0
Retained earnings: -49700189.18918919
Receivables turnover: 2.7438692098092643
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -241.72666956426116
FCF margin (%): -3287.4677259185696
Rule of 40 score: -3287.4677259185696
Financial ratios for CTAI.L — annual report dated 2023-12-31
Total revenue: 36291.13924050633
Gross profit: 36291.13924050633
Operating income: -460529.1139240506
Net income: -330782.2784810126
Capital expenditures: 0
Operating cash flow: -242705.06329113923
Depreciation & amortization: 0
Net tangible assets: -548302.5316455696
Owner earnings: -330782.2784810126
Buffett classification: The Gruesome
Stock price: 0.00012658227848101267
Shares outstanding: 1433860312
Book value: -548301.2658227847
Market cap (USD): 181501.30531645572
Debt to equity: -0.3024300601628044
Current ratio: 0.04090914123130404
Quick ratio: 0.04090914123130404
COGS to revenue (%): 0
SG&A to revenue (%): 631.3637949075688
Free cash flow (dilution-adjusted): -242705.06329113923
Buyback yield (%): 0
Retained earnings: -47591112.658227846
Receivables turnover: 3.675641025641026
Capitalized R&D asset: 0
FCF margin (%): -668.7722357865364
Revenue growth (%): -11.10412764655848
Rule of 40 score: -679.8763634330949
Financial ratios for CTAI.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 505708.75
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1433860312
Book value: 505710
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.3220340928657524
Quick ratio: 3.3220340928657524
Retained earnings: -47156441.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTAI.L — annual report dated 2024-12-31
Total revenue: 164375
Gross profit: 164375
Operating income: -163973.75
Net income: -160217.5
Capital expenditures: 0
Operating cash flow: -842385
Depreciation & amortization: 0
Net tangible assets: 505708.75
Owner earnings: -160217.5
Return on net tangible assets (%): -31.681773352745036
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1433860312
Book value: 505710
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0
Current ratio: 3.3220340928657524
Quick ratio: 3.3220340928657524
COGS to revenue (%): 0
SG&A to revenue (%): 139.13764258555133
Free cash flow (dilution-adjusted): -842385
Retained earnings: -47156441.25
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.42438249099659
FCF margin (%): -512.4775665399239
Revenue growth (%): 352.9342518311824
Rule of 40 score: -159.54331470874155
Financial ratios for CTAI.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1392684.9315068494
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1433860312
Book value: 1392686.301369863
P/B ratio: 0
Market cap (USD): 0
Debt to equity: 0.039344481592192476
Current ratio: 3.03661218987252
Quick ratio: 3.03661218987252
Retained earnings: -51981453.42465754
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYB.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.00787401574803
Shares outstanding: 15684428
Market cap (USD): 784344899.4330708
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYB.TO — annual report dated 2022-12-31
Total revenue: -66240441.176470585
Net income: -59288970.58823529
Capital expenditures: 0
Operating cash flow: -14776470.588235293
Net tangible assets: 1003317647.0588235
Owner earnings: -59288970.58823529
Return on net tangible assets (%): -5.909292113224361
Buffett classification: The Gruesome
Stock price: 41.91176470588235
Shares outstanding: 15684428
Book value: 1003317647.0588233
P/B ratio: 0.6551883721066579
Market cap (USD): 657362055.8823528
Debt to equity: 0.0220225252691072
Free cash flow (dilution-adjusted): -14776470.588235293
Buyback yield (%): 0.05872401796093217
Retained earnings: 841874999.9999999
Receivables turnover: -50.41242305540011
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYB.TO — annual report dated 2023-12-31
Total revenue: 182019696.96969697
Net income: 156218939.39393938
Capital expenditures: 0
Operating cash flow: 18758333.333333332
Net tangible assets: 1182551515.151515
Owner earnings: 156218939.39393938
Return on net tangible assets (%): 13.210328462851257
Buffett classification: The Gruesome
Stock price: 45.916666666666664
P/E ratio: 4.61004699639686
Shares outstanding: 15684428
Book value: 1182551515.1515152
P/B ratio: 0.6090023505158337
Market cap (USD): 720176652.3333333
Debt to equity: 0.03203140615310499
Effective tax rate (%): 11.593140407288317
COGS to revenue (%): 0
SG&A to revenue (%): 1.7684566272381443
Free cash flow (dilution-adjusted): 18758333.333333332
Buyback yield (%): 1.008064960357569
Retained earnings: 1017389393.9393939
Receivables turnover: 69.78390938135348
Capitalized R&D asset: 0
FCF margin (%): 10.305661225475097
Rule of 40 score: 10.305661225475097
Financial ratios for CYB.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 53.34814814814814
Shares outstanding: 15684428
Market cap (USD): 836735188.5629629
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYB.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.92307692307693
Shares outstanding: 15684428
Market cap (USD): 814383761.5384616
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYB.TO — annual report dated 2024-12-31
Total revenue: 166462237.76223776
Net income: 140186013.98601398
Capital expenditures: 0
Operating cash flow: 21764335.664335664
Net tangible assets: 1191883916.0839162
Owner earnings: 140186013.98601398
Return on net tangible assets (%): 11.761717067767192
Buffett classification: The Gruesome
Stock price: 51.92307692307693
P/E ratio: 5.809308206877976
Shares outstanding: 15684428
Book value: 1191883916.0839162
P/B ratio: 0.683274394887567
Market cap (USD): 814383761.5384616
Debt to equity: 0.029335939929382528
Effective tax rate (%): 12.901459854014597
COGS to revenue (%): 0
SG&A to revenue (%): 1.8190143714738218
Free cash flow (dilution-adjusted): 21764335.664335664
Buyback yield (%): 4.897864430899362
Retained earnings: 1044827972.0279721
Receivables turnover: 105.0026466696074
Capitalized R&D asset: 0
FCF margin (%): 13.07463840262812
Revenue growth (%): -8.5471294955783
Rule of 40 score: 4.527508907049819
Financial ratios for CYB.TO — quarterly report dated 2025-03-31
Total revenue: 35589510.48951049
Net income: 30620979.02097902
Capital expenditures: 0
Operating cash flow: 32651048.95104895
Net tangible assets: 1221160139.8601398
Owner earnings: 30620979.02097902
Return on net tangible assets (%): 2.5075318151545676
Buffett classification: The Gruesome
Stock price: 52.05594405594405
P/E ratio: 6.665917719009774
Shares outstanding: 15684428
Book value: 1221160139.8601398
P/B ratio: 0.668600030304783
Market cap (USD): 816467706.5174825
Debt to equity: 0.028632636968513838
Effective tax rate (%): 8.702722989032983
COGS to revenue (%): 0
SG&A to revenue (%): 3.8610417935668955
Free cash flow (dilution-adjusted): 32651048.95104895
Buyback yield (%): 0.16616007538496658
Retained earnings: 1074274825.1748252
Receivables turnover: 4.277441586821315
Capitalized R&D asset: 0
FCF margin (%): 91.74346177273888
Rule of 40 score: 91.74346177273888
Financial ratios for CYB.TO — quarterly report dated 2025-06-30
Total revenue: 51952554.744525544
Net income: 43451824.81751824
Capital expenditures: 0
Operating cash flow: -30038686.131386857
Net tangible assets: 1317872992.7007298
Owner earnings: 43451824.81751824
Return on net tangible assets (%): 3.2971177843528
Buffett classification: The Gruesome
Stock price: 58.124087591240865
P/E ratio: 12.307392452406532
Shares outstanding: 15684428
Book value: 1317872992.7007298
P/B ratio: 0.6917533570684015
Market cap (USD): 911643066.8905108
Debt to equity: 0.02769337452630483
Effective tax rate (%): 11.620345626224834
COGS to revenue (%): 0
SG&A to revenue (%): 3.495609413417632
Free cash flow (dilution-adjusted): -30038686.131386857
Buyback yield (%): 0.10112486385306968
Retained earnings: 1164675182.4817517
Receivables turnover: 27.565840433772273
Capitalized R&D asset: 0
FCF margin (%): -57.81945907973305
Revenue growth (%): 45.97715458839433
Rule of 40 score: -11.842304491338723
Financial ratios for CYB.TO — quarterly report dated 2025-09-30
Total revenue: 119330215.82733814
Net income: 103221582.73381296
Capital expenditures: 0
Operating cash flow: 16779136.690647483
Net tangible assets: 1402131654.676259
Owner earnings: 103221582.73381296
Return on net tangible assets (%): 7.3617611006468575
Buffett classification: The Gruesome
Stock price: 60.4748201438849
P/E ratio: 5.349932283235925
Shares outstanding: 15684428
Book value: 1402131654.676259
P/B ratio: 0.6764792444392222
Market cap (USD): 948512962.3597124
Debt to equity: 0.025654668662257827
Effective tax rate (%): 12.182492563440283
COGS to revenue (%): 0
SG&A to revenue (%): 0.9646166553123248
Free cash flow (dilution-adjusted): 16779136.690647483
Buyback yield (%): 0
Retained earnings: 1251138129.496403
Receivables turnover: 19.504821260583256
Capitalized R&D asset: 0
FCF margin (%): 14.061096407405843
Revenue growth (%): 129.6907561411356
Rule of 40 score: 143.75185254854145
Financial ratios for CYB.TO — quarterly report dated 2025-12-31
Total revenue: 28342335.766423356
Net income: 24966423.35766423
Capital expenditures: 0
Operating cash flow: 25072992.700729925
Net tangible assets: 1447567153.2846713
Owner earnings: 24966423.35766423
Return on net tangible assets (%): 1.724716072826948
Buffett classification: The Gruesome
Stock price: 63.15328467153284
P/E ratio: 4.897256896860512
Shares outstanding: 15684428
Book value: 1447567153.2846713
P/B ratio: 0.684267492631735
Market cap (USD): 990523146.3941604
Debt to equity: 0.02521219846840937
Effective tax rate (%): 6.359679141457003
COGS to revenue (%): 0
SG&A to revenue (%): 3.8527904401349504
Free cash flow (dilution-adjusted): 25072992.700729925
Buyback yield (%): 0
Retained earnings: 1294369343.0656934
Receivables turnover: 13.628992628992629
Capitalized R&D asset: 0
FCF margin (%): 88.46480723170825
Revenue growth (%): -76.24881881766427
Rule of 40 score: 12.215988414043977
Financial ratios for CYB.TO — annual report dated 2025-12-31
Total revenue: 238515328.46715328
Net income: 205821897.81021896
Capital expenditures: 0
Operating cash flow: 46139416.05839416
Net tangible assets: 1447567153.2846713
Owner earnings: 205821897.81021896
Return on net tangible assets (%): 14.218469750656402
Buffett classification: The Gruesome
Stock price: 63.15328467153284
P/E ratio: 4.812525571538003
Shares outstanding: 15684428
Book value: 1447567153.2846713
P/B ratio: 0.684267492631735
Market cap (USD): 990523146.3941604
Debt to equity: 0.02521219846840937
Effective tax rate (%): 10.824657499588874
COGS to revenue (%): 0
SG&A to revenue (%): 2.0112251580641805
Free cash flow (dilution-adjusted): 46139416.05839416
Buyback yield (%): 0.23603246556029647
Retained earnings: 1294369343.0656934
Receivables turnover: 114.6949806949807
Capitalized R&D asset: 0
FCF margin (%): 19.344423838465445
Revenue growth (%): 43.28494658820506
Rule of 40 score: 62.629370426670505
Financial ratios for DEV.AX — annual report dated 2022-06-30
Operating income: -8179572.413793104
Net income: -8213018.620689656
Capital expenditures: 59377.24137931035
Depreciation & amortization: 104508.27586206897
Net tangible assets: 5575695.862068966
Owner earnings: -8167887.586206897
Return on net tangible assets (%): -146.4909096238985
Buffett classification: The Gruesome
Stock price: 0.15172413793103448
Shares outstanding: 710330423
Book value: 5575695.862068966
P/B ratio: 19.32929516637416
Market cap (USD): 107774271.07586206
Debt to equity: 0.053891773397326995
Current ratio: 4.791734168777794
Quick ratio: 4.791734168777794
Interest coverage ratio: -105.05022054525163
Free cash flow (dilution-adjusted): -6430995.172413793
Buyback yield (%): 0
Retained earnings: -51881088.965517245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -124.87181571279307
Rule of 40 score: 0
Financial ratios for DEV.AX — annual report dated 2023-06-30
Operating income: -8813703.973509934
Net income: -8568786.754966887
Capital expenditures: 77030.46357615895
Depreciation & amortization: 111733.77483443709
Net tangible assets: 8254242.38410596
Owner earnings: -8534083.443708608
Return on net tangible assets (%): -103.39026947090262
Buffett classification: The Gruesome
Stock price: 0.1920529801324503
Shares outstanding: 710330423
Book value: 8254242.38410596
P/B ratio: 16.527388979827027
Market cap (USD): 136421074.61589402
Debt to equity: 0.029417985020105255
Current ratio: 6.472327203967404
Quick ratio: 6.472327203967404
Interest coverage ratio: -101.22988514489998
Free cash flow (dilution-adjusted): -8039378.80794702
Buyback yield (%): 0
Retained earnings: -58151883.443708606
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -95.8827464351134
Rule of 40 score: 0
Financial ratios for DEV.AX — annual report dated 2024-06-30
Operating income: -11546138.666666666
Net income: -7190476
Capital expenditures: 187946.66666666666
Depreciation & amortization: 129645.33333333333
Net tangible assets: 15255565.333333334
Owner earnings: -7248777.333333334
Return on net tangible assets (%): -47.515625772941966
Buffett classification: The Gruesome
Stock price: 0.20666666666666667
Shares outstanding: 710330423
Book value: 15255565.333333332
P/B ratio: 9.622824034752258
Market cap (USD): 146801620.75333333
Debt to equity: 0.011459337156433578
Current ratio: 7.656002008931008
Quick ratio: 7.656002008931008
Interest coverage ratio: -54.8652635046948
Free cash flow (dilution-adjusted): -10078762
Buyback yield (%): 0
Retained earnings: -65700360
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -72.09649416430868
Rule of 40 score: 0
Financial ratios for DLPN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.04
Shares outstanding: 13017271
Market cap (USD): 221814297.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLPN — annual report dated 2022-12-31
Total revenue: 40505558
Gross profit: 36939222
Operating income: -3235151
Net income: -4780135
Capital expenditures: 72198
Operating cash flow: -4027228
Depreciation & amortization: 1751211
Net tangible assets: -5107327
Owner earnings: -3101122
Buffett classification: The Gruesome
Stock price: 3.62
Shares outstanding: 13017271
Book value: 34091092
P/B ratio: 1.3822532003374957
Market cap (USD): 47122521.02
Debt to equity: 0.6401548240226509
Current ratio: 0.9436948493159764
Quick ratio: 0.9436948493159764
Interest coverage ratio: -3.7408633532759645
COGS to revenue (%): 8.804559611300752
SG&A to revenue (%): 94.85898700617827
Free cash flow (dilution-adjusted): -4364954
Buyback yield (%): 0
Retained earnings: -109214479
Receivables turnover: 2.5093014474824162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.458781987271863
FCF margin (%): -10.77618533239315
Rule of 40 score: -10.77618533239315
Financial ratios for DLPN — annual report dated 2023-12-31
Total revenue: 43123075
Gross profit: 42176113
Operating income: -6027408
Net income: -24396725
Capital expenditures: 28995
Operating cash flow: -5017167
Depreciation & amortization: 2253619
Net tangible assets: -16472904
Owner earnings: -22172101
Buffett classification: The Gruesome
Stock price: 3.42
Shares outstanding: 13017271
Book value: 19956845
P/B ratio: 2.2307667780152625
Market cap (USD): 44519066.82
Debt to equity: 1.2820835157060146
Current ratio: 0.7548469087160016
Quick ratio: 0.7548469087160016
Interest coverage ratio: -2.8906948180596967
COGS to revenue (%): 2.1959519352458052
SG&A to revenue (%): 106.55525377074804
Free cash flow (dilution-adjusted): -5401123
Buyback yield (%): 0
Retained earnings: -133611204
Receivables turnover: 3.4604835263600306
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.534184761400946
FCF margin (%): -12.524902270999924
Revenue growth (%): 6.462118112284738
Rule of 40 score: -6.062784158715186
Financial ratios for DLPN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.26
Shares outstanding: 13017271
Market cap (USD): 16401761.46
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLPN — annual report dated 2024-12-31
Total revenue: 51684984
Gross profit: 48418523
Operating income: -2329571
Net income: -12603225
Capital expenditures: 1512
Operating cash flow: -157851
Depreciation & amortization: 2382361
Net tangible assets: -20051579
Owner earnings: -10222376
Buffett classification: The Gruesome
Stock price: 1.07
Shares outstanding: 13017271
Book value: 11645391
P/B ratio: 1.1960508642432015
Market cap (USD): 13928479.97
Debt to equity: 2.3717519660782536
Current ratio: 0.7568452633400815
Quick ratio: 0.7568452633400815
Interest coverage ratio: -1.1252884384544675
COGS to revenue (%): 6.319941977731869
SG&A to revenue (%): 93.57792003959989
Free cash flow (dilution-adjusted): -524013
Buyback yield (%): 0
Retained earnings: -146214429
Receivables turnover: 4.892162636606241
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.29743644908136
FCF margin (%): -1.013859267132597
Revenue growth (%): 19.85458829176723
Rule of 40 score: 18.840729024634634
Financial ratios for DLPN — quarterly report dated 2024-12-31
Capital expenditures: 2
Buffett classification: The Gruesome
Stock price: 1.07
Shares outstanding: 13017271
Market cap (USD): 13928479.97
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DLPN — quarterly report dated 2025-03-31
Total revenue: 12169711
Gross profit: 11825297
Operating income: -1357356
Net income: -2329062
Capital expenditures: 1088
Operating cash flow: -1703425
Depreciation & amortization: 591552
Net tangible assets: -21806399
Owner earnings: -1738598
Buffett classification: The Gruesome
Stock price: 1.01
Shares outstanding: 13017271
Book value: 9316329
P/B ratio: 1.411225785392508
Market cap (USD): 13147443.71
Debt to equity: 2.981590710246493
Current ratio: 0.743939441223861
Quick ratio: 0.743939441223861
Interest coverage ratio: -2.4500435910348672
COGS to revenue (%): 2.830091856741709
SG&A to revenue (%): 103.46261303986594
Free cash flow (dilution-adjusted): -1704513
Buyback yield (%): 0
Retained earnings: -148543491
Receivables turnover: 0.9655181250382805
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.50638495502549
FCF margin (%): -14.006191272742633
Rule of 40 score: -14.006191272742633
Financial ratios for DLPN — quarterly report dated 2025-06-30
Total revenue: 14087529
Gross profit: 13345358
Operating income: -57054
Net income: -1413918
Capital expenditures: 0
Operating cash flow: 1505903
Depreciation & amortization: 591552
Net tangible assets: -22646074
Owner earnings: -822366
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 13017271
Book value: 7902411
P/B ratio: 1.894341062493459
Market cap (USD): 14969861.649999999
Debt to equity: 3.632076969927279
Current ratio: 0.7605778647543417
Quick ratio: 0.7605778647543417
Interest coverage ratio: -0.10166030554753734
COGS to revenue (%): 5.268283742308534
SG&A to revenue (%): 90.93759452065724
Free cash flow (dilution-adjusted): 1505903
Buyback yield (%): 0
Retained earnings: -149957409
Receivables turnover: 1.1761230522315276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.19353654297207326
FCF margin (%): 10.68961774630597
Revenue growth (%): 15.758944481097373
Rule of 40 score: 26.448562227403343
Financial ratios for DLPN — quarterly report dated 2025-09-30
Total revenue: 14796309
Gross profit: 14152378
Operating income: 308296
Net income: -365494
Capital expenditures: 29
Operating cash flow: -2406661
Depreciation & amortization: 589388
Net tangible assets: -21543981
Owner earnings: 223865
Capex to operating income (%): 0.009406544359965748
Buffett classification: The Great
Stock price: 1.28
Shares outstanding: 13017271
Book value: 8430263
P/B ratio: 1.9764634721360415
Market cap (USD): 16662106.88
Debt to equity: 3.4746778362667925
Current ratio: 0.819454568084186
Quick ratio: 0.819454568084186
Interest coverage ratio: 0.4909531589893527
COGS to revenue (%): 4.351970481286921
SG&A to revenue (%): 89.58108403926953
Free cash flow (dilution-adjusted): -2418633
Buyback yield (%): 0
Retained earnings: -150322903
Receivables turnover: 1.0046274635213983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0245972330131838
FCF margin (%): -16.346191472481415
Revenue growth (%): 5.031258498207883
Rule of 40 score: -11.314932974273532
Financial ratios for DLPN — annual report dated 2025-12-31
Total revenue: 56699389
Gross profit: 54429515
Operating income: -379461
Net income: -3088768
Capital expenditures: 1117
Operating cash flow: -2027597
Depreciation & amortization: 2354585
Net tangible assets: -19716126
Owner earnings: -735300
Buffett classification: The Gruesome
Stock price: 1.56
Shares outstanding: 13017271
Book value: 9690425
P/B ratio: 2.0955678166850267
Market cap (USD): 20306942.76
Debt to equity: 2.9431141564998438
Current ratio: 0.8395469500411835
Quick ratio: 0.8395469500411835
Interest coverage ratio: -0.17287328065661242
COGS to revenue (%): 4.003348254775726
SG&A to revenue (%): 92.51315036216704
Free cash flow (dilution-adjusted): -2041113
Buyback yield (%): 0
Retained earnings: -149303197
Receivables turnover: 4.330544391957138
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2734394409257845
FCF margin (%): -3.5998853532619197
Revenue growth (%): 9.70186040881816
Rule of 40 score: 6.10197505555624
Financial ratios for DLPN — quarterly report dated 2025-12-31
Total revenue: 15645840
Gross profit: 15106482
Operating income: 726652
Net income: 1019706
Capital expenditures: 0
Operating cash flow: 576586
Depreciation & amortization: 582093
Net tangible assets: -19716126
Owner earnings: 1601799
Return on net tangible assets (%): -8.124309004720299
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.56
P/E ratio: 4.978626868921042
Shares outstanding: 13017271
Book value: 9690425
P/B ratio: 2.0955678166850267
Market cap (USD): 20306942.76
Debt to equity: 2.9431141564998438
Current ratio: 0.8395469500411835
Quick ratio: 0.8395469500411835
Effective tax rate (%): 2.515910262011447
Interest coverage ratio: 1.6301417803302225
COGS to revenue (%): 3.447293338037459
SG&A to revenue (%): 88.18789531274767
Free cash flow (dilution-adjusted): 576130
Buyback yield (%): 0
Retained earnings: -149303197
Receivables turnover: 1.1949865045187464
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4385834555530166
FCF margin (%): 3.6823206679858673
Revenue growth (%): 5.741506209420201
Rule of 40 score: 9.423826877406068
Financial ratios for EAF — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 55000000
Buffett classification: The Gruesome
Stock price: 117.15
Shares outstanding: 26047884
Market cap (USD): 3051509610.6000004
Buyback yield (%): 1.638533263218817
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EAF — annual report dated 2022-12-31
Total revenue: 1281250000
Gross profit: 554877000
Operating income: 474259000
Net income: 382962000
Capital expenditures: 195000
Operating cash flow: 324628000
Depreciation & amortization: 55496000
Net tangible assets: 115051000
Owner earnings: 438263000
Return on net tangible assets (%): 380.9293269941156
Capex to operating income (%): 0.04111677374599112
Buffett classification: The Great
Stock price: 47.41
P/E ratio: 3.22468072665173
Shares outstanding: 26047884
Book value: 337715000
P/B ratio: 3.6567229185555865
Market cap (USD): 1234930180.4399998
Debt to equity: 2.7298965103711708
Current ratio: 3.4274590922086
Quick ratio: 1.4904100028589207
Effective tax rate (%): 15.333460087814323
Interest coverage ratio: 10.584012140418219
COGS to revenue (%): 56.692526829268296
R&D to revenue (%): 0.28417560975609757
SG&A to revenue (%): 6.007960975609756
Free cash flow (dilution-adjusted): 250152000
Buyback yield (%): 4.858574270054869
Retained earnings: -401945000
Inventory turnover: 1.5765663695301597
Receivables turnover: 6.926012616830008
Capitalized R&D asset: 3641000
ROCI (R&D-adjusted, %): 34.79546100988807
FCF margin (%): 19.524058536585365
Rule of 40 score: 19.524058536585365
Financial ratios for EAF — annual report dated 2023-12-31
Total revenue: 620500000
Gross profit: 36212000
Operating income: -43320000
Net income: -255250000
Capital expenditures: 220000
Operating cash flow: 76561000
Depreciation & amortization: 56889000
Net tangible assets: 35874000
Owner earnings: -198581000
Return on net tangible assets (%): -553.5513185036517
Buffett classification: The Gruesome
Stock price: 21.9
Shares outstanding: 26047884
Book value: 78247000
P/B ratio: 7.290358219484452
Market cap (USD): 570448659.5999999
Debt to equity: 11.829782611473922
Current ratio: 3.541421096550385
Quick ratio: 1.7287698839632
Interest coverage ratio: -0.7374495684592207
COGS to revenue (%): 94.16406124093473
R&D to revenue (%): 0.8896051571313457
SG&A to revenue (%): 11.927800161160354
Free cash flow (dilution-adjusted): 18088000
Buyback yield (%): 0
Retained earnings: -662390000
Inventory turnover: 1.6916858721206296
Receivables turnover: 4.772489539748954
Capitalized R&D asset: 7959470
ROCI (R&D-adjusted, %): -3.6928016514884145
Rosenberg metric: -142.45124965668774
FCF margin (%): 2.915068493150685
Revenue growth (%): -51.57073170731707
Rule of 40 score: -48.65566321416639
Financial ratios for EAF — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.2
Shares outstanding: 26047884
Market cap (USD): 343832068.79999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EAF — annual report dated 2024-12-31
Total revenue: 538782000
Gross profit: -19853000
Operating income: -72069000
Net income: -131165000
Capital expenditures: 100000
Operating cash flow: -40093000
Depreciation & amortization: 62245000
Net tangible assets: -113300000
Owner earnings: -69020000
Buffett classification: The Gruesome
Stock price: 17.3
Shares outstanding: 26047884
Book value: -78902000
Market cap (USD): 450628393.20000005
Debt to equity: -13.775506324301032
Current ratio: 4.550857935095656
Quick ratio: 2.7968969977631515
Interest coverage ratio: -1.0131442067084657
COGS to revenue (%): 103.68479273620869
R&D to revenue (%): 1.0590554250141988
SG&A to revenue (%): 8.632433897197753
Free cash flow (dilution-adjusted): -80437000
Buyback yield (%): 0
Retained earnings: -793453000
Inventory turnover: 2.2761479851688873
Receivables turnover: 4.664859997575715
Capitalized R&D asset: 10605930
ROCI (R&D-adjusted, %): -6.513412127671024
Rosenberg metric: -10.156702898550725
FCF margin (%): -14.929414865381545
Revenue growth (%): -13.169701853344076
Rule of 40 score: -28.09911671872562
Financial ratios for EAF — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.3
Shares outstanding: 26047884
Market cap (USD): 450628393.20000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EAF — quarterly report dated 2025-03-31
Total revenue: 111839000
Gross profit: -1709000
Operating income: -18210000
Net income: -39351000
Capital expenditures: 29000
Operating cash flow: -32186000
Depreciation & amortization: 13783000
Net tangible assets: -137841000
Owner earnings: -25597000
Buffett classification: The Gruesome
Stock price: 8.74
Shares outstanding: 26047884
Book value: -105340000
Market cap (USD): 227658506.16
Debt to equity: -10.336652743497247
Current ratio: 4.163030017498991
Quick ratio: 2.451716247139588
Interest coverage ratio: -0.7651581999243666
COGS to revenue (%): 101.52808948577868
R&D to revenue (%): 1.680093706131135
SG&A to revenue (%): 13.074151235257824
Free cash flow (dilution-adjusted): -43047000
Buyback yield (%): 0
Retained earnings: -832452000
Inventory turnover: 0.44656994419252205
Receivables turnover: 1.2482588508415555
Capitalized R&D asset: 1879000
ROCI (R&D-adjusted, %): -1.598162326948475
FCF margin (%): -38.49015102066363
Rule of 40 score: -38.49015102066363
Financial ratios for EAF — quarterly report dated 2025-06-30
Total revenue: 131840000
Gross profit: 62000
Operating income: -14553000
Net income: -86886000
Capital expenditures: 4000
Operating cash flow: -53236000
Depreciation & amortization: 15562000
Net tangible assets: -199037000
Owner earnings: -71328000
Buffett classification: The Gruesome
Stock price: 9.73
Shares outstanding: 26047884
Book value: -168435000
Market cap (USD): 253445911.32000002
Debt to equity: -6.476154005996379
Current ratio: 4.950369671228567
Quick ratio: 2.713762606400643
Interest coverage ratio: -0.6114962813563595
COGS to revenue (%): 99.95297330097087
R&D to revenue (%): 1.0224514563106797
SG&A to revenue (%): 10.062955097087379
Free cash flow (dilution-adjusted): -58987000
Buyback yield (%): 0
Retained earnings: -919338000
Inventory turnover: 0.5149066527042974
Receivables turnover: 1.4526703174410789
Capitalized R&D asset: 2606930
ROCI (R&D-adjusted, %): -1.4277712179685325
Rosenberg metric: 0.94252261841405
FCF margin (%): -44.74135315533981
Revenue growth (%): 17.88374359570454
Rule of 40 score: -26.857609559635268